Your Visual Guide Schwannoma

Understand this diagnosis through data, infographics, and evidence based on modern classification and current research.

~3,500
New Vestibular Schwannoma Cases/Year (U.S.)
Understanding Schwannoma
What Is Schwannoma & How Is It Classified?
Schwannomas are benign nerve sheath tumors arising from Schwann cells. Classification is primarily by nerve of origin, with NF2-associated vs sporadic distinction guiding management.
Nerve Sheath Tumor
Nerve of Origin?
Vestibular (CN VIII)
Vestibular (CN VIII) (~90%)
Most common; acoustic neuroma
Sporadic NF2-associated
Trigeminal (CN V)
Trigeminal (CN V) (~5%)
Facial numbness/pain
Posterior fossa Middle fossa
Spinal
Spinal (~3%)
Radiculopathy, myelopathy
Intradural Dumbbell-shaped
Other Cranial/Peripheral
Other Cranial/Peripheral (~2%)
CN VII, XII, or peripheral nerves
Facial nerve Peripheral
Tumor Grading
Schwannoma Classification by Location
Schwannomas are classified primarily by the nerve of origin and association with genetic syndromes.
1
Vestibular Schwannoma
Most common type (~90% of intracranial schwannomas). Arises from vestibular nerve (CN VIII). Causes hearing loss, tinnitus, balance issues.
2
Trigeminal Schwannoma
Second most common intracranial schwannoma. Facial numbness, pain, or weakness. May extend across posterior and middle fossa.
3
Facial Nerve Schwannoma
Rare. Progressive facial weakness, possible hearing loss. Arises from any segment of CN VII.
4
Spinal Schwannoma
Most common intradural-extramedullary spinal tumor. Radicular pain, weakness, sensory changes.
5
Peripheral Schwannoma
Arises from peripheral nerves in limbs or trunk. Palpable mass, Tinel sign, neurological deficit along nerve distribution.
6
NF2-related Schwannoma
Bilateral vestibular schwannomas are hallmark of NF2. Multiple schwannomas in schwannomatosis (LZTR1/SMARCB1 mutations).
Molecular Markers
The Key Biomarkers
Modern classification depends on specific molecular markers. Each reveals something different about the tumor.
Diagnostic
NF2
Merlin (Neurofibromin 2)
Biallelic NF2 loss in >90% of schwannomas. Merlin loss activates mTOR/Hippo pathways. Defines NF2 syndrome when germline.
Universal marker
Diagnostic
LZTR1
Leucine Zipper-like Regulator
Germline mutations cause schwannomatosis type 2. Multiple schwannomas without vestibular involvement.
Schwannomatosis
Diagnostic
SMARCB1
SWI/SNF Chromatin Remodeler
Germline mutations cause schwannomatosis type 1. Predisposes to multiple schwannomas and schwannomas.
Schwannomatosis
Diagnostic
SOX10
SRY-Box Transcription Factor
Nuclear staining confirms Schwann cell origin. Useful for differential diagnosis with other spindle cell tumors.
Lineage marker
Diagnostic
S100
S100 Protein
Strong diffuse positivity is characteristic. Classic IHC marker for schwannoma diagnosis.
Standard marker
Prognostic
Ki-67
Proliferation Index
Low Ki-67 (<5%) is typical of benign schwannoma. Elevated index may suggest malignant transformation.
Growth indicator
Signs & Symptoms
Schwannoma Signs & Symptoms
Symptoms depend on the nerve of origin and tumor size. Vestibular schwannoma typically presents with gradual hearing loss.

Hearing Loss

Progressive unilateral sensorineural hearing loss is the most common presenting symptom of vestibular schwannoma.

Tinnitus

Ringing, buzzing, or rushing sounds in the affected ear. Often an early symptom.

Balance Problems

Unsteadiness, vertigo, disequilibrium due to vestibular nerve dysfunction.

Facial Symptoms

Facial numbness (trigeminal schwannoma), weakness (facial nerve schwannoma), or hemifacial spasm.

Brainstem Compression

Large tumors can cause headache, hydrocephalus, ataxia, and cranial nerve palsies.

Spinal Symptoms

Radicular pain, weakness, and sensory changes along the affected nerve root distribution.

Diagnosis
The Diagnostic Journey
From first hearing test to treatment decision — the path to a schwannoma diagnosis.
1

Audiometry

Pure tone and speech audiometry reveals asymmetric sensorineural hearing loss

2

MRI with Gadolinium

Gold standard: brightly enhancing mass in internal auditory canal or cerebellopontine angle

3

ABR Testing

Auditory brainstem response testing for screening; prolonged wave latencies

4

CT Temporal Bone

Evaluates bone erosion, widening of internal auditory canal, surgical planning

5

Genetic Testing

NF2/LZTR1/SMARCB1 testing when bilateral tumors or multiple schwannomas suspected

6

Treatment Plan

Based on Koos grade, hearing status, age, and patient preferences (observe vs treat)

Treatment
Treatment Options for Schwannoma
Treatment depends on tumor size, hearing status, growth rate, and patient preferences. Observation is often appropriate.

Observation

Watch-and-wait with serial MRI for small, stable tumors. Appropriate for many patients, especially elderly or with serviceable hearing.

Microsurgery

Retrosigmoid, translabyrinthine, or middle fossa approaches. Goal: complete removal with facial nerve preservation. Koos grade guides approach.

Stereotactic Radiosurgery

Gamma Knife or CyberKnife for tumors <2.5-3cm. Excellent tumor control (~95%). Hearing preservation ~50-70%.

Fractionated Radiation

Fractionated stereotactic radiotherapy for larger tumors. Similar control to SRS with potentially less cranial nerve toxicity.

Bevacizumab

Anti-VEGF therapy for NF2-related schwannomas. Tumor shrinkage and hearing improvement in ~40% of patients.

Clinical Trials

MEK inhibitors, mTOR inhibitors, and novel targeted agents for NF2-related and growing schwannomas.

Find matching trials →
Care Team
Your Multidisciplinary Care Team
Schwannoma management often involves a team balancing tumor control with hearing and facial nerve preservation.
Core Specialists

Neurosurgeon

Primary specialist for surgical resection and skull base approaches

Radiation Oncologist

Plans and delivers radiation therapy and stereotactic radiosurgery

Neuro-oncologist

For higher-grade or refractory schwannomas requiring systemic therapy

Support Team

Neuroradiologist

Specialized imaging interpretation and monitoring

Neuropathologist

Tissue analysis, WHO grading, and molecular profiling

Nurse Navigator

Guides you through appointments, insurance, and logistics

Resources
Support Organizations
Organizations providing information, community, and support for schwannoma patients and families.

Acoustic Neuroma Association

Dedicated support for acoustic neuroma/vestibular schwannoma patients with resources, forums, and education.

Visit Acoustic Neuroma Association →

Children's Tumor Foundation

Supporting NF2 and schwannomatosis research, clinical care, and patient services.

Visit Children's Tumor Foundation →

National Brain Tumor Society

Leading nonprofit investing in research, advocacy, and patient services for all brain tumors.

Visit National Brain Tumor Society →

American Brain Tumor Association

Comprehensive brain tumor information, patient support programs, and research funding.

Visit American Brain Tumor Association →

Want to Explore Clinical Trials?

Search clinical trials for schwannoma and find the ones that match your specific diagnosis.

Find Clinical Trials &rarr;